Navigation Links
Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
Date:5/1/2008

nformation please contact:

Porter Novelli for Shire:

Lucia Lodato

Lucia.Lodato@porternovelli.com

212.601.8037

917.617.3058 (on site at the meeting)

Lauren Plate

Lauren.Plate@porternovelli.com

212.601.8188

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results. For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development including, but not limited to the successful development of JUVISTA(R) (Human TGF(beta)3) and veleglucerase alfa (GA-GCB); manufacturing and commerc
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
2. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
3. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
4. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
5. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
6. Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
7. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
10. Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
11. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... TUCSON, Ariz. , Aug. 20, 2014 /PRNewswire/ ... of the  Roche  Group, today announced that its ... been CE marked in the European Union for ... specimens. The system, consisting of VENTANA Virtuoso software ... the VENTANA iScan HT slide scanner, provides automated ...
(Date:8/20/2014)... Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces that ... has received Chinese FDA (CFDA) approval and has ... into the China domestic ... distribution agreement with Sinochem Jiangsu Pharmaceutical Co., Ltd., ... FDA approved and China CFDA certified oral solid ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: The Market for Medical Devices ... The European, Middle Eastern and African markets represent ... part of its coverage, this study: The Market ... EMEA medical device markets and estimates markets for ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5
...   " The   Obama administration will ... urban counterparts in adopting technology to improve healthcare quality." ... online health records . " What ... national healthcare IT programmes and initiatives are currently taking place across ...
... WHITE PLAINS, N.Y., Aug. 19, 2011 Today the ... to treat two types of rare blood cancers – ... (Logo: http://photos.prnewswire.com/prnh/20110215/NY48642LOGO) The drug is approved ... cell transplant or two chemotherapy treatments and for ALCL ...
Cached Medicine Technology:Innovations in E-Health & Informatics Europe: The Need for a European EHealth Strategy 2The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics' Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977 2
(Date:8/20/2014)... 21, 2014 Medical Alert Systems, ... reviews of some of the most popular medical alert ... to announce that it is now offering special deals ... who are on a fixed income but would like ... comes as very welcome news. , As a company ...
(Date:8/20/2014)... August 21, 2014 iFitDress.com, the well-known ... range of cheap evening gowns . All ... of them are priced under $100. , iFitDress.com ... market. It keeps trying its best to help clients ... all its members are kind and professional. According to ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Today, ... announced the publication of a new eBook, Affordable ... many small business owners feel uncertain about how ... family, and their bottom line. , The new ... and helps businesses navigate their upcoming health insurance ...
(Date:8/20/2014)... Dennis Thompson HealthDay Reporter ... birth rates fell dramatically during the past two decades, plummeting ... government report shows. An estimated 4 million fewer births ... to researchers from the U.S. Centers for Disease Control and ... me from the report," said Bill Albert, chief program officer ...
(Date:8/20/2014)... An imaging study of chronic users of codeine-containing ... regions of brain white matter and associates these ... , Researchers used diffusuion tensor imaging (DTI) (an ... investigate the white matter integrity of chronic CCS ... the brain, including the inferior fronto-occipital fasciculus, which ...
Breaking Medicine News(10 mins):Health News:Medical Alert Systems Website Now Offering Special Prices on the Popular Medical Guardian Product 2Health News:Medical Alert Systems Website Now Offering Special Prices on the Popular Medical Guardian Product 3Health News:iFitDress.com Releases a New Range of Cheap Evening Gowns 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 3
... Osteoarthritis is commonly diagnosed in the late and irreversible ... pain and slow progression of disease. Because osteoarthritis is ... and veterinarians need a precise way to diagnose the ... are investigating potential biomarkers in dogs for early diagnosis ...
... , -- New Tissue Dissection System Used by Italian Surgeons ... , PALO ALTO, Calif., June 10 PEAK Surgical, ... System by surgeons in the European Union, where the innovative ... , , Dr. Raul Pellini and Prof. Giuseppe Spriano, ...
... House will help eliminate barriers that discourage doctors from ... 10 Late yesterday U.S. Senators Arlen Specter (PA) ... access to life-saving diagnostic tests for patients who might ... Tests Act (S. 1220) will eliminate the complicated Medicare ...
... Canadian Hospital Specialties, to release EchoStim(R) and EchoBlock(R) ... CINCINNATI, June 10 Havel,s Incorporated, a Cincinnati-based ... CHS, Canadian Hospital Specialties, which will become the ... Needles throughout Canada. , , Canadian Hospital ...
... to Program Would Increase Threat of Disease , , PHILADELPHIA, ... Protection Secretary John Hanger today asked Pennsylvanians to make every effort ... Virus. , , Hanger said standing water can quickly become ... the simple rule of dump it, drain it and treat it. ...
... WALTHAM, Mass., June 10 Millennium Research Group (MRG), ... that despite the economic downturn, market growth in the ... increased colorectal cancer (CRC) screening programs in France, Germany, ... released European Markets for GI Endoscopy Devices 2009 ...
Cached Medicine News:Health News:Early detection of osteoarthritis in dogs could open doors for a cure 2Health News:PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe 2Health News:PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe 3Health News:PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe 4Health News:Legislation Will Expand Access to Life-Saving Laboratory Tests 2Health News:Havel's Incorporated Expands Successful EchoStim(R) Ultrasound Needles into Canada 2Health News:DEP Asks Pennsylvanians to Help Battle West Nile Virus 2Health News:DEP Asks Pennsylvanians to Help Battle West Nile Virus 3Health News:Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group 2Health News:Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group 3
... An APTT-based kit for the screening of ... specificity of the test for the factor ... sample plasma with an excess of V-DEF ... possible to discriminate between heterozygous and homozygous ...
Inquire...
Inquire...
... remarkable anti-reflux valve is enclosed ... which prevents the valve from ... in sitting or reclining positions. ... and interference free ensuring uninterrupted ...
Medicine Products: